Drugs like Zepbound and Wegovy are intended for people who are overweight. Some patients are using them after bariatric surgery to keep pounds from creeping back. Others may just want to lose a few ...

US Democrats seek to scrap statute of limitations for sex abuse crimes in bill named after Epstein accuser.

CARSON, Calif. (KABC) -- Friends, relatives and civil rights advocates gathered at a candlelight vigil on Saturday night to remember a man killed by an off-duty Immigration and Customs Enforcement ...

Donald Trump’s decision to allow Nvidia Corp. to sell advanced chips to China marks more than just a shift in US tech policy. It also raises questions about how far he’ll go to steady ties with Xi ...

COVERAGE CONUNDRUM — For state Medicaid programs, choosing whether or not to cover weight-loss medications is not a simple decision. Medicaid officials across the country are being presented with what ...

Weight-loss drugs are coming for a new kind of customer. “You don’t need to be obese to start a GLP-1,” reads an ad from a telehealth startup, the words scrawled in icing on a cake. Another one ...

Treatment with a GLP-1 receptor agonist (RA) may offer a survival advantage in patients with colon cancer and obesity. In a real-world analysis of nearly 7000 patients with colon cancer, those taking ...

It has now been one year since Donald Trump pulled a Grover Cleveland, winning a second nonconsecutive term in the White House, while the Republicans took both houses of Congress in a “red sweep.” ...

Editor’s note: This work is part of AI Watchdog, The Atlantic’s ongoing investigation into the generative-AI industry. The Common Crawl Foundation is little known outside of Silicon Valley. For more ...

Dothée is a writer in Los Angeles. On Oct. 16, President Trump promised to slash the price of brand-name GLP-1 drugs like Ozempic and Wegovy to $150 a month. Even after a top health official suggested ...

We may earn commission from links on this page, but we only recommend products we love. Promise. Boot season is arguably the best season. And knowing how to style boots with your dresses opens up a ...

Eight percent of US adults older than 65 years have taken a GLP-1 agonist either to lose weight or to treat comorbidities like diabetes and cardiovascular disease. Older adults are drawn to the ...